Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Per Jensen Mikkelsen has worked on the following 2 EPO patent applications which have been published in the last five years:

EP14710541

ANTIBODIES CAPABLE OF SPECIFICALLY BINDING TWO EPITOPES ON TISSUE FACTOR PATHWAY INHIBITOR

IPC classification:
C07K 16/38, C07K 16/46
Applicant:
Novo Nordisk A/S
Agent:
Per Jensen Mikkelsen, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED
EP15704530

COAGULATION FACTOR IX CONJUGATES

IPC classification:
A61K 47/48, A61P 7/02
Applicant:
Novo Nordisk Health Care AG
Agent:
Witte, Weller & Partner Patentanwälte mbB
Agent:
Per Jensen Mikkelsen, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature